retatrutide diabetes trial for type 1 Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, people with 2 diabetes: a randomised, double-blind, placebo Diabetes Dialogue: Retatrutide Reduces Body

Not tighter yet, but like there was more substance underneath

It's important to note that GLP-1 therapy works best alongside consistent lifestyle habits: balanced nutrition, regular movement, and adequate sleep become even more important during menopause

Extracellular Matrix Research Tool: Fibroblast studies report collagen-related effects at very low concentrations, suggesting a targeted impact on matrix processes rather than cell growth alone

This includes a peptide known as Melanotan II, a synthetic drug which stimulates the body's ability to produce melanin

Inositol and choline in lipid metabolism and insulin sensitivity